Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome.
Delluc
A
A
Limal
N
N
Puéchal
X
X
Francès
C
C
Piette
J C
JC
Cacoub
P
P
D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008875:Middle Aged; D017472:Receptors, Interleukin-1 / Q000627:therapeutic use; D016463:Sweet Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
D003879:Dermatologic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1